ThyCa To Award 3 New Thyroid Cancer Research Grants in 2013 Grants Open to Researchers Worldwide

Proposals Due by January 31, 2013

ThyCa: Thyroid Cancer Survivors’ Association Inc., announces the 11th year of its research grants program, with grants open to researchers and institutions worldwide. ThyCa will award 3 new grants for thyroid cancer research in 2012.

Each grant will be for 2 years. One grant is for research on follicular-cell-derived thyroid cancer (papillary, follicular, anaplastic, and variants). Another is for research on medullary thyroid cancer. The third grant is for research on any type of thyroid cancer. It is named The Ric Blake Memorial Thyroid Cancer Research Grant, in memory and honor of ThyCa co-founder Ric Blake.

The winning grant recipients will be selected by an independent expert panel of the American Thyroid Association (ATA). ATA is the professional association of clinicians and researchers specializing in thyroid diseases. The grant application guidelines are on ATA’s web site. The deadline for submitting a proposal summary to ATA is January 31, 2013.

ATA’s Research Committee will rank proposals according to their scientific merit. The authors of selected proposals will be notified by the ATA as early as March; they will be invited to submit complete grant applications, from which the grant winners will be selected.

ThyCa is committed to supporting research with the goal of cures for all thyroid cancer. The ThyCa Grants began in 2003. They are the first grants to be funded entirely by thyroid cancer patients, caregivers and friends. ThyCa has awarded more than $900,000 for thyroid cancer research, to researchers in France, Germany, Sweden, Switzerland, and the United States.ThyCa has awarded grants to researchers at the following institutions;

• Beth Israel Deaconess Medical Center (Harvard Medical School), Boston, Massachusetts
• Cancer Center Karolinska, Stockholm, Sweden
• Cochin Institut, Paris, France
• Harvard Medical School, Boston, Massachusetts
• Johns Hopkins University School of Medicine, Baltimore, Maryland
• Memorial Sloan-Kettering Cancer Center, New York, New York
• Ohio State University, Columbus, Ohio, and Medical University of Gdansk, Poland
• Penn State Hershey Cancer Institute, Hershey, Pennsylvania
• Rush-Presbyterian-St. Luke’s Medical Center, Chicago, Illinois
• University of California Los Angeles/Veterans Affairs West Los Angeles Health Care System, Los Angeles, California
• University Hospital Basel, Basel, Switzerland
• University Hospital Duesseldorf, Duesseldorf, Germany
• University of Arkansas for Medical Sciences, Little Rock, Arkansas
• University of Illinois at Chicago, Illinois
• University of Texas M.D. Anderson Cancer Center, Houston, Texas
• Washington Hospital Center/Georgetown University, Washington, D.C.

To find out more about the ThyCa Research Funds and the annual Rally for Research, please visit our Research Funds page.

Thyca invites everyone to join us in our quest to find a cure for all thyroid cancer.